CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Precision Biosensor Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Precision Biosensor Inc
306, Techno 2-ro, Yuseong-gu
Phone: +82 428676300p:+82 428676300 Daejeon, 34036  South Korea Ticker: 335810335810
Business Summary
PrecisionBiosensor Inc is a Korea-based company mainly engaged in the development, manufacture and sale of in vitro diagnostic reagents. The Company's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The Company sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Internal Auditor Sang HyeonSul 50 9/27/2024 9/27/2024
Non-Executive Independent Director Hyeok JongLee 53 9/27/2024 9/27/2024
Non-Executive Independent Director Yeong SeungSong 50 9/27/2024 9/27/2024

General Information
Outstanding Shares: 11,614,526 (As of 6/30/2024)
Shareholders: 14,389
Stock Exchange: KDQ
Fax Number: +82 428676302


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 21, 2024